Alfasigma

Alfasigma Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan).

Pharmaceuticals with passion
Our mission is to improve people's health and quality of life by offering caregivers and healthcare professionals therapeutic solutions according to the highest standards of quality and safety, in the name of innovation. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy,

the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo). Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers. It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.

🏀 Huge congratulations to Virtus Segafredo Bologna on winning their 17th Italian Championship yesterday!At Alfasigma, we...
18/06/2025

🏀 Huge congratulations to Virtus Segafredo Bologna on winning their 17th Italian Championship yesterday!

At Alfasigma, we’re proud to have supported this team for many years as the naming sponsor of , standing by their side through both challenges and great victories.

This win is the result of bold choices, teamwork, determination, and a clear vision — a perfect reflection of what we believe in.
Well done to the players, staff, club, and all the fans!

On this , we firmly stand with the global community to support better healthcare for everyone across the world.“Healthy...
07/04/2025

On this , we firmly stand with the global community to support better healthcare for everyone across the world.
“Healthy beginnings, hopeful futures” is the title of this year’s campaign, urging us to remember that the health of mothers and babies is the foundation of healthy families and communities, helping ensure hopeful futures for us all.

Let’s work together to make it possible!

Gender equality does not happen in a vacuum! Acceleration requires collaboration, determination, and collective action. ...
08/03/2025

Gender equality does not happen in a vacuum!
Acceleration requires collaboration, determination, and collective action. Around the world, organizations and individuals are uniting to drive progress in key areas like women’s economic empowerment, leadership, and representation in STEM.
Globally, women hold just 31.7% of senior leadership roles – and that’s not good enough.

At Alfasigma, we’ve surpassed this number, but we’re still eager to accelerate our efforts and have more women contribute to our business.
An inclusive environment only makes us better!


Source: World Economic Forum, Global Gender Gap 2024, Insight Report June 2024

Today is !Every rare disease tells a unique story, more than you can imagine.A disease is considered rare when it affec...
28/02/2025

Today is !
Every rare disease tells a unique story, more than you can imagine.
A disease is considered rare when it affects fewer than 1 in 2,000 people, but for those living with one, rarity does not mean invisibility.

Patients with rare diseases face multiple challenges every day:
💡 Delayed diagnosis due to limited scientific knowledge and complex symptoms
⚕️ Difficult access to treatment and care, leading to inequalities
🔄 Misdiagnosis, as many rare diseases share symptoms with more common conditions
🌍 The need for global commitment to connect experts and drive innovation

At Alfasigma, we believe that no disease is too rare to deserve attention. We are committed to addressing patients’ needs and innovating to create life-changing solutions. Together, we can do more.


Source: www.rarediseaseday.org

17/02/2025

Alfasigma is proud to have supported 2024, the charity rally organized by the humanitarian association Associazione umanitaria Tavolo 8 ODV to raise awareness and funds for cooperation projects benefiting the most vulnerable groups in West Africa.

Marina Golinelli, Deputy Chairman of Alfasigma, took part in the rally as a member of the Rusty Penguins team. This 6,023 km journey saw participants raise donations and helped spread the word about the projects and initiatives in West Africa by sharing updates on social media.

At the end of this journey, the vehicles were donated to local communities in Africa to support Tavolo8’s humanitarian projects. Our car, "Sally," will continue to make important journeys at the Catholic mission of Suzana in Guinea-Bissau, enabling them to provide essential medical care to women and families in remote local communities.

This initiative reflects our belief that even a small gesture can make a lasting impact by creating a strong, supportive, and collaborative community.

23/12/2024

As we approach the festive season and the end of another year, we want to thank all of you: our partners, colleagues, and community, for being part of our journey.

We are excited to continue this journey with you in the year ahead.
From all of us, warm wishes for joyful celebrations and an inspiring start to 2025!

Is it possible to travel with confidence while living with Ulcerative Colitis? Travel is one of life’s most enriching ex...
20/12/2024

Is it possible to travel with confidence while living with Ulcerative Colitis? Travel is one of life’s most enriching experiences, and a diagnosis of Ulcerative Colitis should not prevent you from exploring the world and embracing new opportunities.

While the symptoms of Ulcerative Colitis can present challenges, thoughtful planning and the right precautions enable many people to fully enjoy their travels, experiencing adventure, relaxation, and breathtaking destinations.

At Alfasigma, we are dedicated to helping individuals manage their health effectively, ensuring that travel remains an accessible and rewarding experience.

💬 What’s your next destination?
👉 Swipe through to discover essential tips for traveling with Ulcerative Colitis

🚙🌍 We’re proud to announce our support to Rust2Dakar 2024, the charity rally aimed at helping the most fragile communiti...
17/12/2024

🚙🌍 We’re proud to announce our support to Rust2Dakar 2024, the charity rally aimed at helping the most fragile communities in West Africa! A proper on the road adventure that crosses Morocco, Mauritania, Senegal and Guinea Bissau. The vehicles used by participants in the Rust2Dakar will be donated in Africa to support Tavolo 8's local projects, either being used in cooperation initiatives or to fund them.

With enthusiasm and determination, Marina Golinelli, Deputy Chairman of Alfasigma, will join the race as member of the Rusty Penguins team, that will set off on December 26th on board of the car “Sally”. A journey in which learning to dare and working effectively as a team will be two fundamental elements to face the challenges of the path and reach the finish line on January 10.

Rust2Dakar is organized by the humanitarian association Associazione umanitaria Tavolo 8 ODV with the goal of raising awareness and funds for cooperation projects aiding the most vulnerable groups in West Africa.

🐧 Why Rusty Penguins? Because just as they’re a symbol of adaptability and resilience in extreme environments, so this team perfectly embodies the spirit of the Rust2Dakar!

This is how you can join and foster the race:

👉 Stay updated watching the Rust2Dakar Instagram Stories and interact by voting on the contents of the Rusty Penguins team

👉 Support Tavolo8 with a donation on the Rust2Dakar 2024 on Rete del Dono website. Make sure to include the Rusty Penguins name and the team number 54 in the "Add a message to your donation" section.

🌍 More than 10 million people worldwide live with inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerat...
06/12/2024

🌍 More than 10 million people worldwide live with inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, according to the Crohn’s & Colitis Foundation. Many individuals living with these conditions may navigate physical, psychological, and social challenges

December 1-7 marks Crohn’s and Colitis Awareness Week, an opportunity to spotlight these challenges and to stand in solidarity with patients, families, and caregivers.

This week, let’s come together to increase awareness of IBD, encourage early diagnosis, and advocate for continuous research and innovative therapies that can transform lives.

🌍 More than 10 million people worldwide live with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerat...
06/12/2024

🌍 More than 10 million people worldwide live with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, according to the Crohn's & Colitis Foundation. Many individuals living with these conditions may navigate physical, psychological, and social challenges

December 1-7 marks Crohn's and Colitis Awareness Week, an opportunity to spotlight these challenges and to stand in solidarity with patients, families, and caregivers.

This week, let’s come together to increase awareness of IBD, encourage early diagnosis, and advocate for continuous research and innovative therapies that can transform lives.

04/11/2024

At Alfasigma, we believe our production plants are more than just workplaces, they are communities.
This fall, we brought that vision to life with the first edition of our Family Days, held across our Italian production plants in Trezzano Rosa, Sermoneta, Pomezia, and Alanno.

During these events, employees welcomed their families into the heart of our operations, opening the doors of departments, laboratories and warehouses that form the backbone of our daily work. It was a chance to share the and that drive us and to celebrate the collaboration, the sense of belonging and the dedication at the core of . In addition to the guided tours of the departments, the plants came alive with numerous recreational activities for all ages.

We are grateful to each person who made these initiative possible and to all the colleagues and families who joined us with such a joyful participation.

🩸 On the occasion of , which took place yesterday, we join the global conversation to raise awareness about thrombosis,...
14/10/2024

🩸 On the occasion of , which took place yesterday, we join the global conversation to raise awareness about thrombosis, a serious condition that consists of the formation of a blood clot in a blood vessel. Early detection, prevention, and timely treatment are crucial to reducing the global impact of thrombosis and potentially saving lives.

Since at , vascular health is a key therapeutic area, we understand the critical role of education and research in addressing thrombotic conditions.

In particular, Chronic Venous Insufficiency (CVI), which can often be underestimated, may increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) if not properly managed.

Let’s work together to enhance awareness and improve outcomes for patients worldwide.


Sources: worldthrombosisday.org

Indirizzo

Via Ragazzi Del '99, 5
Bologna
40133

Telefono

+390516849511

Sito Web

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Alfasigma pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta L'azienda

Invia un messaggio a Alfasigma:

Scelte rapide

Condividi

Digitare

Pharmaceuticals with Passion

Alfasigma, one of the leading Italian pharmaceutical companies, is present in over 90 countries, through distributors and subsidiaries and has a workforce of around 3,000 people, R&D laboratories, and 5 production plants.

In Italy Alfasigma is a leader in the market for prescription products where, in addition to the strong focus on Gastro-Intestinal, it is present in many primary care therapeutic areas. It also produces and markets self-medication products, nutraceuticals and food supplements.

More information is available at the Alfasigma website at: http://www.alfasigma.com/en